Heron Therapeutics (HRTX) COO acquires 125,000 shares via RSU exercise
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Heron Therapeutics Chief Operating Officer Mark Earl Hensley exercised equity awards and increased his direct share holdings. On May 6, 2026, he exercised derivative securities to acquire 125,000 shares of common stock, reflecting the settlement of restricted stock units as equity compensation rather than a cash purchase.
Following the transaction, he directly holds 136,770 shares of common stock and 375,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock and vests 25% on the first anniversary of the grant date of May 6, 2025, then in twelve equal quarterly installments thereafter.
Positive
- None.
Negative
- None.
Insider Trade Summary
125,000 shares exercised/converted
Mixed
2 txns
Insider
Hensley Mark Earl
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 125,000 | $0.00 | -- |
| Exercise | Common Stock | 125,000 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 375,000 shares (Direct, null);
Common Stock — 136,770 shares (Direct, null)
Footnotes (1)
- Each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units vest with 25% upon the first anniversary of date of grant (May 6, 2025) and then in twelve (12) equal quarterly installments thereafter.
Key Figures
Common shares acquired: 125,000 shares
Common shares held after: 136,770 shares
Restricted stock units held: 375,000 RSUs
+3 more
6 metrics
Common shares acquired
125,000 shares
Shares of common stock delivered on May 6, 2026
Common shares held after
136,770 shares
Direct ownership after the reported transactions
Restricted stock units held
375,000 RSUs
RSU balance following the derivative transaction
Transaction price per share
$0.0000 per share
Indicates equity compensation settlement, not cash purchase
Initial vesting portion
25%
RSUs vest 25% on first anniversary of May 6, 2025 grant
Remaining vesting installments
12 installments
Equal quarterly installments after first anniversary vesting
Key Terms
Restricted Stock Units, derivative security, contingent right, vest
4 terms
Restricted Stock Units financial
"The restricted stock units vest with 25% upon the first anniversary"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
contingent right financial
"Each restricted stock unit represents a contingent right to receive one share"
vest financial
"The restricted stock units vest with 25% upon the first anniversary"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
What insider transaction did Heron Therapeutics (HRTX) report for Mark Earl Hensley?
Heron Therapeutics reported that Chief Operating Officer Mark Earl Hensley exercised derivative securities to acquire 125,000 shares of common stock. The transaction reflects equity compensation settlement, not an open-market purchase, and increased his direct ownership position in the company’s common stock.
What are the details of the 125,000 restricted stock units for Heron Therapeutics (HRTX)?
The 125,000 restricted stock units each represent a contingent right to receive one Heron Therapeutics common share. They vest 25% on the first anniversary of the May 6, 2025 grant date, then in twelve equal quarterly installments, aligning compensation with ongoing service over time.
How many restricted stock units does Mark Earl Hensley hold in Heron Therapeutics (HRTX)?
Following the transaction, Mark Earl Hensley holds 375,000 restricted stock units in Heron Therapeutics. These units provide rights to receive common shares upon vesting under the disclosed schedule, complementing his directly held 136,770 common shares after the reported exercise event.
What does the vesting schedule mean for Heron Therapeutics (HRTX) restricted stock units?
The vesting schedule means 25% of the restricted stock units vest on the first anniversary of the May 6, 2025 grant date. The remaining units then vest in twelve equal quarterly installments, gradually converting into common shares as service conditions are satisfied over time.